Mediclinic International PLC Surges to 52-Week Low, Is Now Worst Performer

 Mediclinic International PLC Surges to 52 Week Low, Is Now Worst Performer

The stock of Mediclinic International PLC (LON:MDC) hit a new 52-week low and has GBX 692.79 target or 9.00% below today’s GBX 761.31 share price. The 7 months bearish chart indicates high risk for the GBX 4.73 billion company. The 1-year low was reported on Nov, 11 by Barchart.com. If the GBX 692.79 price target is reached, the company will be worth GBX 425.70 million less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. The stock decreased 1.89% or GBX 14.69 on November 11, hitting GBX 761.31. About 4.18 million shares traded hands or 205.11% up from the average. Mediclinic International PLC (LON:MDC) has declined 19.26% since April 15, 2016 and is downtrending. It has underperformed by 25.40% the S&P500.

Mediclinic International PLC (LON:MDC) Ratings Coverage

Out of 10 analysts covering Mediclinic International (LON:MDC), 3 rate it a “Buy”, 1 “Sell”, while 6 “Hold”. This means 30% are positive. Mediclinic International has been the topic of 16 analyst reports since February 18, 2016 according to StockzIntelligence Inc. The company was downgraded on Monday, September 12 by Citigroup. HSBC maintained Mediclinic International PLC (LON:MDC) rating on Friday, November 11. HSBC has “Reduce” rating and GBX 745 price target. The firm has “Hold” rating given on Tuesday, July 26 by Jefferies. The firm earned “Buy” rating on Monday, May 9 by Investec. The firm has “Buy” rating by UBS given on Tuesday, September 6. As per Tuesday, August 23, the company rating was maintained by JP Morgan. Citigroup maintained the shares of MDC in a report on Thursday, February 18 with “Neutral” rating. The company was maintained on Thursday, September 22 by Jefferies. The rating was maintained by Investec with “Buy” on Monday, March 14. The firm has “Buy” rating given on Tuesday, June 28 by Citigroup.

More news for Mediclinic International PLC (LON:MDC) were recently published by: Fool.Co.Uk, which released: “Paddy Power Betfair PLC Ord Eur0.09 & Mediclinic International PLC Set To …” on February 29, 2016. Fool.Co.Uk‘s article titled: “Are Mediclinic International plc, AstraZeneca plc and Smith & Nephew plc the …” and published on May 25, 2016 is yet another important article.

Mediclinic International plc, formerly Al Noor Hospitals Group plc, is a holding company. The company has a market cap of 4.73 billion GBP. The Firm operates as an international private healthcare provider. It has a 18.12 P/E ratio. The Company’s divisions include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment